Back

Prognostic value of pulmonary hypertension in patients with advanced heart failure evaluated fort heart replacement therapy in the light of new definition of pulmonary hypertension.

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: The growing importance of phenotyping in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Annamaria Minervini

University Hospital of Bologna S. Orsola-Malpighi Polyclinic, Bologna (Italy)

5 More presentations in this session

Presentation thumbnail
Transthyretin amyloid cardiomyopathy among patients with hypertrophic cardiomyopathy: clinical, cardiac imaging, and electrocardiographic findings from the TTRACK study
Professor P. Garcia-Pavia (Majadahonda, ES)
Abstract Slides Video
Presentation thumbnail
Associations of fasting state glycemic biomarkers with mortality and morbidity in heart failure: Retrospective cohort study
Doctor K. Iwasaki (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Usefulness of a scoring evaluation for practical introduction of the guideline-directed medical therapy (GDMT) in heart failure patients
Doctor R. Matsukawa (Iizuka, JP)
Abstract Slides Video
Presentation thumbnail
Level of education and mortality in the vulnerable period following an acute heart failure hospitalization
Doctor G. Pereira Da Cunha (Curitiba, BR)
Abstract Slides Video
Presentation thumbnail
Red cell distribution width (RDW) to serum albumin ratio (RAR) in chronic heart failure
Doctor A. Toste (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
The growing importance of phenotyping in heart failure

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources